We are international
Donate
• myeloma tv TEXT SIZE   
webcasts from medical meetings    back

Phase I evaluation of carfilzomib (PR-171) in hematological malignancies: Responses in multiple myeloma and Waldenstrom's macroglobulinemia at well-tolerated doses.
06.10.07

Be the first to comment

 related articles